PCCTC Investigator Dr Andrew Armstrong on PCWG4's Amended Terminology and Biomarker Standards for Advanced Prostate Ccancer

Apr 21

Written By Kristofer Prepelica, PhD

Kristofer Prepelica, PhD

Results of the Phase 2 Trial of Olaparib + Radium-223 vs Radium-223 in Men With CRPC With Bone Metastases (COMRADE) led by the PCCTC’s Dr McKay published in JCO

First Quadruplet Therapy Regimen Shows Promise for Men with High-Volume Metastatic APMN Prostate Cancer